Sarah K. Lynam MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer (NCT05113368) | Sarah K. Lynam MD | 2022-06-28 |
Track Sarah K. Lynam MD automatically
Every clearance here is in the API, with alerts when new ones post.